CEL-SCI Stock Drops After Raising $31.7M Via Secondary Equity Offering

 


  • CEL-SCI Corporation (NYSE:CVMhas increased the size of its previously announced capital raise offering to 1.4 million shares, up from 1 million shares, at $22.62 per share representing a 5% discount to Tuesday's closing price of $23.82 per share.

  • The offering is expected to close by June 11.

  • Underwriters have an option to purchase up to 15% of the offering.

  • The proceeds will be used to fund the continued development of the pipeline based on Multikine and LEAPS technologies and other general corporate purposes.

  • For the quarter that ended on March 31, the company reported a cash balance of $6.4 million.

  • In the Q2 earnings release, the company said it is preparing for the anticipated commercial launch of Multikine, CEL-SCI, which has been expanding and upgrading its dedicated cGMP manufacturing facility.

  • Price Action: CVM shares are down 9.2% at $21.62 during the premarket session on the last check Wednesday.


  •  

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

 

 

 


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: BiotechNewsHealth CareOfferingsSmall CapGeneralBriefs